Change in CFO
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jubilant Pharmova announced the resignation of Mr. Arun Kumar Sharma as CFO, effective close of business on May 22, 2026. Sharma will transition to an advisory role as Advisor to the Chairmen. The Board simultaneously approved the appointment of Mr. Ashish Mukkirwar as the new CFO and KMP, effective May 23, 2026. Mukkirwar joins from Glenmark Pharmaceuticals where he served as Group Vice President & CFO for their Global Formulations Business. He brings over two decades of experience in corporate finance, M&A, and investor relations.
The transition represents a routine executive change at the CFO level. The outgoing CFO's move to an advisory role suggests a planned succession rather than an abrupt departure. The new CFO's strong background in strategy and capital markets from his Glenmark role could bring fresh perspective to the company's financial leadership.